Lynda Charters

Why instillation of topical corticosteroids may be associated with greater ptosis and higher rate of failed ptosis repair

A study in the United Arab Emirates reported a possible link between adverse ocular events and a COVID-19 vaccination.

Development of new animal model enhances study of potential mutations.

Scanning laser ophthalmoscopy offers improved view of posterior segment.

Reports indicate the variant was first detected in Colombia in early 2021 and has currently spread to 39 countries including the United States.

Study examines immunomodulatory therapy as a potential long-term treatment option.

Investigators searched PubMed over the past 2 decades for clinical trials on eyelid ptosis using the terms blepharoptosis or upper eyelid ptosis or eyelid ptosis” and the filters “randomized controlled trial (RCT), clinical trial, and humans.”

Corticosteroids and antibiotics may be indicated in patients with severe rhinosinusitis until either IgG4-related or bacterial rhinosinusitis can be ruled out.

A team of investigators at McMaster University in Toronto has found that fluvoxamine reduced hospitalizations by up to 30 percent.

In PIONEER study, investigators outline their successes.

Experts provide perspectives on current care and pipeline products.

A team of UK researchers further examine the rare thrombocytopenia and thromboembolic events occurring after COVID-19 vaccinations.

Investigation evaluates safety of single and multiple intravitreal injections.

Regeneron Pharmaceuticals announced at an ongoing Phase 2 trial has met its primary safety endpoint with no new safety signals observed.

Researchers conducted a retrospective observational study to assess the corneal refractive changes induced by surgery to correct ptosis using Fourier harmonic analysis.

Advances help gain clearer image, enhancing decision-making process.

Investigators study the systemic adverse physiologic effects of the virus that causes COVID-19.

The EURETINA 2021 Virtual Meeting is scheduled for Sept. 9 to 12, and retina specialists eagerly await the showcase of cutting-edge scientific developments.

A study suggests that for the general population, evaluation for blepharoptosis should be done at 66 years of age, or at 63 and 70 years for males and females, separately.

Scientists have developed a new approach that is less complex and does not require extracting the genetic RNA material of the virus.

GT005 designed to induce local production of recombinant complement factor I.

Philip Rosenfeld, MD, PhD, presents results from a natural history study of patients that results in recognition of hypertransmission defects on en face OCT.

Cotargeted therapy could help combat inherited retinal diseases.

Tool for quantifying measures may predict outcomes for patients.

Substantial weight loss can help patients’ eye health, study results show.

Most patients with allergic disorder are children, adolescents, or young adults.

Llama nanobodies may be key to beating COVID-19 variants.

Region may have world’s highest rate, investigators say.

Investigators from various companies described their diagnostic offerings at the Glaucoma Research Foundation’s 2021 New Horizons Forum.

Clinical trials show subretinal agents are safe, well tolerated by patients.